Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m

Published on August 18, 2026

LEO Pharma, which the release describes as a global leader in medical dermatology, serves close to 100 million patients in more than 70 countries annually.

The post Nordic Capital-backed LEO Pharma to acquire dersimelagon rights from Bain-owned Tanabe for $435m appeared first on PE Hub.

Continue reading on website
Other news

Private equity energy power players + A venture studio stakes out agricultural innovation in Southeast Asia

August 18, 2026
Greetings Agents of Impact! Welcome to ImpactAlpha Open, a free weekly sampling of the top news and views from ImpactAlpha. Get the ImpactAlpha ...The post Private equity energy power players + A venture studio stakes out agricultural innovation in Southeast Asia appeared first on ImpactAlpha.

Reach Capital closes $265 million for fifth fund and a focus on inclusive AI

August 18, 2026
Artificial intelligence is supercharging founders’ work in reshaping how people learn, live and earn. Reach Capital is looking for the founders leveraging AI ...The post Reach Capital closes $265 million for fifth fund and a focus on inclusive AI appeared first on ImpactAlpha.